Gelteq Limited (NASDAQ:GELS) Short Interest Update

Gelteq Limited (NASDAQ:GELS) saw a large decrease in short interest in December. As of December 15th, there was short interest totaling 40,613 shares, a decrease of 86.9% from the November 30th total of 309,448 shares. Based on an average daily trading volume, of 96,833 shares, the short-interest ratio is presently 0.4 days. Currently, 0.4% of the company’s stock are sold short. Currently, 0.4% of the company’s stock are sold short. Based on an average daily trading volume, of 96,833 shares, the short-interest ratio is presently 0.4 days.

Institutional Trading of Gelteq

An institutional investor recently bought a new position in Gelteq stock. Susquehanna International Group LLP acquired a new position in Gelteq Limited (NASDAQ:GELS) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 41,550 shares of the company’s stock, valued at approximately $57,000. Susquehanna International Group LLP owned 0.44% of Gelteq at the end of the most recent reporting period.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Gelteq in a report on Monday. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Gelteq currently has a consensus rating of “Sell”.

Gelteq Stock Down 2.7%

Shares of GELS stock traded down $0.02 during mid-day trading on Friday, reaching $0.85. The stock had a trading volume of 22,465 shares, compared to its average volume of 1,364,164. The business’s fifty day moving average is $1.06 and its 200-day moving average is $1.40. Gelteq has a 1-year low of $0.77 and a 1-year high of $4.11.

About Gelteq

Gelteq Inc is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition. Gelteq Inc is based in NEW YORK.